Nick Cammack

3.2k citations

43 papers · 2.4k · h-index 28

Impact in

Virology top 0.5%
- HIV Research and Treatment
Hepatology top 0.5%
- Hepatitis C virus research

Papers in

Infectious Diseases 32
- HIV/AIDS drug development and treatment 32
Virology 20
- HIV Research and Treatment 20

Co-authors: Isabel Nájera (11 shared papers)Klaus Klumpp (12 shared papers)Sonal Rajyaguru (8 shared papers)Sophie Le Pogam (9 shared papers)Julian Symons (7 shared papers)Vincent Lévêque (10 shared papers)Wen-Rong Jiang (6 shared papers)Hyunsoon Kang (6 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (7 papers)AIDS (7 papers)Journal of Biological Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)Virology (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Nick Cammack

43 papers receiving 2.2k citations

Peers

Countries citing papers authored by Nick Cammack

Since Specialization

Citations

This map shows the geographic impact of Nick Cammack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Cammack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Cammack more than expected).

Fields of papers citing papers by Nick Cammack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Cammack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Cammack. The network helps show where Nick Cammack may publish in the future.

Co-authors

The 25 scholars most cited alongside Nick Cammack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nick Cammack Line = papers co-authored together Nick Cammack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture Journal of Biological Chemistry ·Klaus Klumpp, Vincent Lévêque, Sophie Le Pogam, Han Ma, Wen-Rong Jiang, Hyunsoon Kang, Caroline Granycome, Margaret Singer, Carl Laxton, Julie Q. Hang, Keshab Sarma, David B. Smith, Dieter Heindl, Chris Hobbs, John H. Merrett, Julian Symons, Nick Cammack, Joseph A. Martin, René Devos, Isabel Nájera	2005	167
2	A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism PLoS Medicine ·Monique Nijhuis, Noortje M. van Maarseveen, Stéphane Lastère, P Schipper, Eoin Coakley, Bärbel Glass, Mirka Rovenska, Dorien de Jong, Colombe Chappey, Irma W Goedegebuure, Gabrielle Heilek‐Snyder, Dominic Dulude, Nick Cammack, Léa Brakier‐Gingras, Jan Konvalinka, Neil Parkin, Hans‐Georg Kräusslich, Françoise Brun‐Vézinet, Charles A. Boucher	2007	138
3	The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors Antimicrobial Agents and Chemotherapy ·Matthew F. McCown, Sonal Rajyaguru, Sophie Le Pogam, Samir Ali, Wen-Rong Jiang, Hyunsoon Kang, Julian Symons, Nick Cammack, Isabel Nájera	2008	132
4	Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates AIDS ·Prakash Sista, Tom Melby, Donna K. Davison, Lei Jin, Sarah Mosier, Mike Mink, Emily L. Nelson, Ralph DeMasi, Nick Cammack, Miklos Salgo, (unknown), Michael Greenberg	2004	127
5	Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) AIDS ·Hans‐Jürgen Stellbrink, Jan van Lunzen, Michael Westby, Eithne O’Sullivan, Claus Schneider, (unknown), Lutwin Weitner, Birger Kuhlmann, Christian Hoffmann, Stefan Fenske, Philipp S. Aries, Olaf Degen, Christian Eggers, H. Petersen, Friedrich Haag, Heinz A. Horst, Klaus Dalhoff, Christiane Möcklinghoff, Nick Cammack, Klara Tenner‐Racz, Paul Rácz	2002	103
6	Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus Journal of Virology ·Sophie Le Pogam, Hyunsoon Kang, Seth F. Harris, Vincent Lévêque, Anthony M. Giannetti, Samir Ali, Wen-Rong Jiang, Sonal Rajyaguru, Gisele Tavares, Connie Oshiro, Than Hendricks, Klaus Klumpp, Julian Symons, Michelle F. Browner, Nick Cammack, Isabel Nájera	2006	103
7	In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance Virology ·Sophie Le Pogam, Wen-Rong Jiang, Vincent Lévêque, Sonal Rajyaguru, Han Ma, Hyunsoon Kang, Sharon Jiang, Margaret Singer, Samir Ali, Klaus Klumpp, Dave Smith, Julian Symons, Nick Cammack, Isabel Nájera	2006	101
8	Translation deficiency of the sabin type 3 poliovirus genome: Association with an attenuating mutation C472 → U Virology ·Yuri V. Svitkin, Nick Cammack, Philip D. Minor, Jeffrey W. Almond	1990	98
9	GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796 Antimicrobial Agents and Chemotherapy ·Matthew F. McCown, Sonal Rajyaguru, Simran Kular, Nick Cammack, Isabel Nájera	2009	96
10	Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex AIDS ·Mark A. Wainberg, Horacio Salomón, Zhengxian Gu, Julio Montaner, Timothy P. Cooley, Ronald P. McCaffrey, John Ruedy, Hilary M. Hirst, Nick Cammack, J. M. Cameron, Wendy Nicholson	1995	95
11	Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex AIDS ·Mark A. Wainberg, Horacio Salomón, Zhengxian Gu, Julio Montaner, Timothy P. Cooley, Ronald P. McCaffrey, John Ruedy, Hilary M. Hirst, Nick Cammack, J. M. Cameron, Wendy Nicholson	1995	83
12	Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479 Antimicrobial Agents and Chemotherapy ·Samir Ali, Vincent Lévêque, Sophie Le Pogam, Han Ma, Friederike Philipp, Nicole Inocencio, Mark Smith, André Alker, Hyunsoon Kang, Isabel Nájera, Klaus Klumpp, Julian Symons, Nick Cammack, Wen-Rong Jiang	2008	82
13	Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Inhibitor β-d-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and Identification of a Novel Active 5′-Triphosphate Species Journal of Biological Chemistry ·Han Ma, Wen-Rong Jiang, Nicole L. Robledo, Vincent Lévêque, Samir Ali, Teresa Lara‐Jaime, Mohammad R. Masjedizadeh, David B. Smith, Nick Cammack, Klaus Klumpp, Julian Symons	2007	79
14	Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus Journal of Biological Chemistry ·Julie Q. Hang, Yanli Yang, Seth F. Harris, Vincent Lévêque, Hannah J. Whittington, Sonal Rajyaguru, Gloria Ao-Ieong, Matthew F. McCown, April Wong, Anthony M. Giannetti, Sophie Le Pogam, Francisco X. Talamás, Nick Cammack, Isabel Nájera, Klaus Klumpp	2009	71
15	The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine Journal of Medicinal Chemistry ·David B. Smith, Genadiy Kalayanov, Christian Sund, Anna Winqvist, T. V. Maltseva, Vincent Lévêque, Sonal Rajyaguru, Sophie Le Pogam, Isabel Nájera, Kurt Benkestock, Xiaoxiong Zhou, Ann C. Kaiser, Hans Maag, Nick Cammack, Joseph A. Martin, Steven Swallow, Nils Gunnar Johansson, Klaus Klumpp, Mark A. Smith	2009	70
16	HIV fusion and its inhibition in antiretroviral therapy Reviews in Medical Virology ·Michael Greenberg, Nick Cammack, Miklos Salgo, Lynn Smiley	2004	56
17	Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains Antimicrobial Agents and Chemotherapy ·Jürgen Schanzer, Andreas Jekle, Jun‐ichi Nezu, Adriane Lochner, Rebecca Croasdale, Marianna Dioszegi, Jun Zhang, Eike Hoffmann, Wilma Dormeyer, Jan Olaf Stracke, Wolfgang Schäfer, Changhua Ji, Gabrielle Heilek, Nick Cammack, Michael R. Brandt, Pablo Umaña, Ulrich Brinkmann	2011	54
18	Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors Virology ·Han Ma, Vincent Lévêque, Anniek De Witte, Weixing Li, Than Hendricks, Saundra M. Clausen, Nick Cammack, Klaus Klumpp	2004	52
19	HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy AIDS ·Charles Craig, Esther Race, Jonathan G. Sheldon, Lynne Whittaker, (unknown), Alec Moffatt, Jane S. L. Rose, Shobana R. Dissanayeke, Gung‐Wei Chirn, I. B. R. Duncan, Nick Cammack	1998	52
20	Anti-Human Immunodeficiency Virus and Anti-Hepatitis-B Virus Activities and Toxicities of the Enantiomers of 2'-Deoxy-3'-oxa-4'-thiocytidine and Their 5-Fluoro Analogs in Vitro Journal of Medicinal Chemistry ·Tarek S. Mansour, Haolun Jin, Wei Wang, Elizabeth U. Hooker, Clare Ashman, Nick Cammack, Horacio Salomón, A. Belmonte, Mark A. Wainberg	1995	45

About Nick Cammack

Nick Cammack is a scholar working on Infectious Diseases, Virology, Hepatology, Epidemiology and Immunology, having authored 43 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (20 papers), Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (9 papers), Immune Cell Function and Interaction (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Biochemical and Molecular Research (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Virology (873 citations), Hepatology (892 citations), Infectious Diseases (1.4k citations), Epidemiology (711 citations) and Immunology (199 citations). Nick Cammack has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Isabel Nájera, Klaus Klumpp, Sonal Rajyaguru, Sophie Le Pogam, Julian Symons, Vincent Lévêque, Wen-Rong Jiang, Hyunsoon Kang, Matthew F. McCown and Samir Ali. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, AIDS, Journal of Biological Chemistry, Journal of Medicinal Chemistry and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Nick Cammack

Impact in

Papers in i

In The Last Decade

Nick Cammack

Peers

Countries citing papers authored by Nick Cammack

Fields of papers citing papers by Nick Cammack

All Works

About Nick Cammack

Explore authors with similar magnitude of impact

Papers in